A citation-based method for searching scientific literature

Katherine Af Lang. Expert Rev Mol Diagn 2013
Times Cited: 2







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The integration of next-generation sequencing panels in the clinical cancer genetics practice: an institutional experience.
Caitlin B Mauer, Sara M Pirzadeh-Miller, Linda D Robinson, David M Euhus. Genet Med 2014
50
100

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
50


The evolution of cancer risk assessment in the era of next generation sequencing.
Heather Fecteau, Kristen J Vogel, Kristen Hanson, Shannon Morrill-Cornelius. J Genet Couns 2014
42
50

Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes.
Laurent Castéra, Sophie Krieger, Antoine Rousselin, Angélina Legros, Jean-Jacques Baumann, Olivia Bruet, Baptiste Brault, Robin Fouillet, Nicolas Goardon, Olivier Letac,[...]. Eur J Hum Genet 2014
151
50

Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium.
Jonathan S Berg, Laura M Amendola, Christine Eng, Eliezer Van Allen, Stacy W Gray, Nikhil Wagle, Heidi L Rehm, Elizabeth T DeChene, Matthew C Dulik, Fuki M Hisama,[...]. Genet Med 2013
87
50

Cancer risk assessment using genetic panel testing: considerations for clinical application.
Susan Hiraki, Erica S Rinella, Freya Schnabel, Ruth Oratz, Harry Ostrer. J Genet Couns 2014
27
50


Collaboration of colorado cancer genetic counselors to integrate next generation sequencing panels into clinical practice.
K Wolfe Schneider, A Anguiano, L Axell, C Barth, K Crow, M Gilstrap, B A Hamlington, S Lesh, L Mullineaux, A Kulchak Rahm,[...]. J Genet Couns 2014
7
50

Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients.
Holly LaDuca, A J Stuenkel, Jill S Dolinsky, Steven Keiles, Stephany Tandy, Tina Pesaran, Elaine Chen, Chia-Ling Gau, Erika Palmaer, Kamelia Shoaepour,[...]. Genet Med 2014
205
50

Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer.
H J Järvinen, M Aarnio, H Mustonen, K Aktan-Collan, L A Aaltonen, P Peltomäki, A De La Chapelle, J P Mecklin. Gastroenterology 2000
913
50

Qualitative data analysis for health services research: developing taxonomy, themes, and theory.
Elizabeth H Bradley, Leslie A Curry, Kelly J Devers. Health Serv Res 2007
50

Perspectives on post-treatment cancer care: qualitative research with survivors, nurses, and physicians.
Maria E Hewitt, Annette Bamundo, Rebecca Day, Catherine Harvey. J Clin Oncol 2007
169
50

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
50


Translating genomics in cancer care.
Yvonne Bombard, Peter B Bach, Kenneth Offit. J Natl Compr Canc Netw 2013
47
50


Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members.
Heikki J Järvinen, Laura Renkonen-Sinisalo, Katja Aktán-Collán, Päivi Peltomäki, Lauri A Aaltonen, Jukka-Pekka Mecklin. J Clin Oncol 2009
170
50


Cancer patients' and patient advocates' perspectives on a novel information source: a qualitative study of the art of oncology, when the tumor is not the target.
Kristin S Vickers, Julie C Hathaway, Christi A Patten, Matthew M Clark, Teresa L Britt, Sherry A Looker, Phaedra T Johnson, Charles L Loprinzi. J Clin Oncol 2005
9
50

Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment.
Allison W Kurian, Emily E Hare, Meredith A Mills, Kerry E Kingham, Lisa McPherson, Alice S Whittemore, Valerie McGuire, Uri Ladabaum, Yuya Kobayashi, Stephen E Lincoln,[...]. J Clin Oncol 2014
294
50


Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
50


Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores.
Julie Lecarpentier, Valentina Silvestri, Karoline B Kuchenbaecker, Daniel Barrowdale, Joe Dennis, Lesley McGuffog, Penny Soucy, Goska Leslie, Piera Rizzolo, Anna Sara Navazio,[...]. J Clin Oncol 2017
64
50

BRCA1 and BRCA2 families and the risk of skin cancer.
Ophira M Ginsburg, Charmaine Kim-Sing, William D Foulkes, Parviz Ghadirian, Henry T Lynch, Ping Sun, Steven A Narod. Fam Cancer 2010
22
50

Cowden's disease: a cutaneous marker of breast cancer.
M H Brownstein, M Wolf, J B Bikowski. Cancer 1978
175
50

BRCA1/2 mutation analysis in male breast cancer families from North West England.
D G R Evans, Mike Bulman, Karen Young, Emma Howard, Stuart Bayliss, Andrew Wallace, Fiona Lalloo. Fam Cancer 2008
26
50

Cancer risks among BRCA1 and BRCA2 mutation carriers.
E Levy-Lahad, E Friedman. Br J Cancer 2007
203
50

Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma.
Spring Holter, Ayelet Borgida, Anna Dodd, Robert Grant, Kara Semotiuk, David Hedley, Neesha Dhani, Steven Narod, Mohammad Akbari, Malcolm Moore,[...]. J Clin Oncol 2015
187
50

Limited family structure and BRCA gene mutation status in single cases of breast cancer.
Jeffrey N Weitzel, Veronica I Lagos, Carey A Cullinane, Patricia J Gambol, Julie O Culver, Kathleen R Blazer, Melanie R Palomares, Katrina J Lowstuter, Deborah J MacDonald. JAMA 2007
130
50

Prediction of pathogenic mutations in patients with early-onset breast cancer by family history.
Fiona Lalloo, Jennifer Varley, David Ellis, Anthony Moran, Lindsay O'Dair, Paul Pharoah, D Gareth R Evans. Lancet 2003
118
50

Men in the women's world of hereditary breast and ovarian cancer--a systematic review.
Nina Strømsvik, Målfrid Råheim, Nina Oyen, Eva Gjengedal. Fam Cancer 2009
21
50

Preimplantation diagnosis for p53 tumour suppressor gene mutations.
Yury Verlinsky, Svetlana Rechitsky, Oleg Verlinsky, Kangu Xu, Glenn Schattman, Christina Masciangelo, Norman Ginberg, Charles Strom, Zev Rosenwaks, Anver Kuliev. Reprod Biomed Online 2001
41
50

Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.
Jeffrey N Weitzel, Kathleen R Blazer, Deborah J MacDonald, Julie O Culver, Kenneth Offit. CA Cancer J Clin 2011
142
50

Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.
Nadine Tung, Chiara Battelli, Brian Allen, Rajesh Kaldate, Satish Bhatnagar, Karla Bowles, Kirsten Timms, Judy E Garber, Christina Herold, Leif Ellisen,[...]. Cancer 2015
246
50

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004
690
50

Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories.
Renea A Taylor, Michael Fraser, Julie Livingstone, Shadrielle Melijah G Espiritu, Heather Thorne, Vincent Huang, Winnie Lo, Yu-Jia Shiah, Takafumi N Yamaguchi, Ania Sliwinski,[...]. Nat Commun 2017
102
50


Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study.
Elizabeth K Bancroft, Elizabeth C Page, Elena Castro, Hans Lilja, Andrew Vickers, Daniel Sjoberg, Melissa Assel, Christopher S Foster, Gillian Mitchell, Kate Drew,[...]. Eur Urol 2014
141
50

Variants in the ATM gene associated with a reduced risk of contralateral breast cancer.
Patrick Concannon, Robert W Haile, Anne-Lise Børresen-Dale, Barry S Rosenstein, Richard A Gatti, Sharon N Teraoka, T Anh Diep, Laila Jansen, David P Atencio, Bryan Langholz,[...]. Cancer Res 2008
35
50

Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions.
April D Sorrell, Carin R Espenschied, Julie O Culver, Jeffrey N Weitzel. Mol Diagn Ther 2013
56
50

Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers.
T Golan, Z S Kanji, R Epelbaum, N Devaud, E Dagan, S Holter, D Aderka, S Paluch-Shimon, B Kaufman, R Gershoni-Baruch,[...]. Br J Cancer 2014
182
50

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.
B B Roa, A A Boyd, K Volcik, C S Richards. Nat Genet 1996
539
50

CHEK2 (∗) 1100delC Mutation and Risk of Prostate Cancer.
Victoria Hale, Maren Weischer, Jong Y Park. Prostate Cancer 2014
28
50

Interest in genetic testing among affected men from hereditary prostate cancer families and their unaffected male relatives.
Julie N Harris, Deborah J Bowen, Alan Kuniyuki, Laura McIntosh, Liesel M FitzGerald, Elaine A Ostrander, Janet L Stanford. Genet Med 2009
4
50

Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.
C J van Asperen, R M Brohet, E J Meijers-Heijboer, N Hoogerbrugge, S Verhoef, H F A Vasen, M G E M Ausems, F H Menko, E B Gomez Garcia, J G M Klijn,[...]. J Med Genet 2005
252
50

Hereditary breast and ovarian cancer: review and future perspectives.
Michael P Lux, Peter A Fasching, Matthias W Beckmann. J Mol Med (Berl) 2006
113
50

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.
Mark E Robson, Angela R Bradbury, Banu Arun, Susan M Domchek, James M Ford, Heather L Hampel, Stephen M Lipkin, Sapna Syngal, Dana S Wollins, Noralane M Lindor. J Clin Oncol 2015
283
50



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.